Key result
Protein S-glutathionylation operates as a biological redox switch in cell survival and death, serving as a valuable biomarker for oxidative stress with potential for novel therapeutic strategies.
Protein S-glutathionylation serves as a biological redox switch and a potential biomarker for oxidative stress with implications for novel therapeutic strategies.
May position S-glutathionylation as oxidative stress biomarker; leaves open therapeutic targeting pending clinical validation.
The interaction between antioxidant glutathione and the free thiol in susceptible cysteine residues of proteins leads to reversible protein S-glutathionylation. This reaction ensures cellular homeostasis control (as a common redox-dependent post-translational modification associated with signal transduction) and intervenes in oxidative stress-related cardiovascular pathology (as initiated by redox imbalance). The purpose of this review is to evaluate the recent knowledge on protein S-glutathionylation in terms of chemistry, broad cellular intervention, specific quantification, and potential for therapeutic exploitation. The data bases searched were Medline and PubMed, from 2009 to 2014 (term: glutathionylation). Protein S-glutathionylation ensures protection of protein thiols against irreversible over-oxidation, operates as a biological redox switch in both cell survival (influencing kinases and protein phosphatases pathways) and cell death (by potentiation of apoptosis), and cross-talks with phosphorylation and with S-nitrosylation. Collectively, protein S-glutathionylation appears as a valuable biomarker for oxidative stress, with potential for translation into novel therapeutic strategies.
No takes yet. Share an insight, caveat, or question.
Doina Popov (2014) conducted a review in oxidative stress-related cardiovascular pathology. Protein S-glutathionylation was evaluated. Protein S-glutathionylation operates as a biological redox switch in cell survival and death, serving as a valuable biomarker for oxidative stress with potential for novel therapeutic strategies.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: